The	O
Runx	O
-	O
PU	O
.	O
1	O
pathway	O
preserves	O
normal	O
and	O
AML	O
/	O
ETO9a	O
leukemic	O
stem	O
cells	O
.	O


Runx	O
transcription	O
factors	O
contribute	O
to	O
hematopoiesis	O
and	O
are	O
frequently	O
implicated	O
in	O
hematologic	O
malignancies	O
.	O


All	O
three	O
Runx	O
isoforms	O
are	O
expressed	O
at	O
the	O
earliest	O
stages	O
of	O
hematopoiesis	O
;	O
however	O
,	O
their	O
function	O
in	O
hematopoietic	O
stem	O
cells	O
(	O
HSCs	O
)	O
is	O
not	O
fully	O
elucidated	O
.	O


Here	O
,	O
we	O
show	O
that	O
Runx	O
factors	O
are	O
essential	O
in	O
HSCs	O
by	O
driving	O
the	O
expression	O
of	O
the	O
hematopoietic	O
transcription	O
factor	O
PU	O
.	O
1	O
.	O


Mechanistically	O
,	O
by	O
using	O
a	O
knockin	O
mouse	O
model	O
in	O
which	O
all	O
three	O
Runx	O
binding	O
sites	O
in	O
the	O
-	O
14kb	O
enhancer	O
of	O
PU	O
.	O
1	O
are	O
disrupted	O
,	O
we	O
observed	O
failure	O
to	O
form	O
chromosomal	O
interactions	O
between	O
the	O
PU	O
.	O
1	O
enhancer	O
and	O
its	O
proximal	B-PROMOTER
promoter	E-PROMOTER
.	O


Consequently	O
,	O
decreased	O
PU	O
.	O
1	O
levels	O
resulted	O
in	O
diminished	O
long	O
-	O
term	O
HSC	O
function	O
through	O
HSC	O
exhaustion	O
,	O
which	O
could	O
be	O
rescued	O
by	O
reintroducing	O
a	O
PU	O
.	O
1	O
transgene	O
.	O


Similarly	O
,	O
in	O
a	O
mouse	O
model	O
of	O
AML	O
/	O
ETO9a	O
leukemia	O
,	O
disrupting	O
the	O
Runx	O
binding	O
sites	O
resulted	O
in	O
decreased	O
PU	O
.	O
1	O
levels	O
.	O


Leukemia	O
onset	O
was	O
delayed	O
,	O
and	O
limiting	O
dilution	O
transplantation	O
experiments	O
demonstrated	O
functional	O
loss	O
of	O
leukemia	O
-	O
initiating	O
cells	O
.	O


This	O
is	O
surprising	O
,	O
because	O
low	O
PU	O
.	O
1	O
levels	O
have	O
been	O
considered	O
a	O
hallmark	O
of	O
AML	O
/	O
ETO	O
leukemia	O
,	O
as	O
indicated	O
in	O
mouse	O
models	O
and	O
as	O
shown	O
here	O
in	O
samples	O
from	O
leukemic	O
patients	O
.	O


Our	O
data	O
demonstrate	O
that	O
Runx	O
-	O
dependent	O
PU	O
.	O
1	O
chromatin	O
interaction	O
and	O
transcription	O
of	O
PU	O
.	O
1	O
are	O
essential	O
for	O
both	O
normal	O
and	O
leukemia	O
stem	O
cells	O
.	O
